Raltitrexed and radiotherapy as adjuvant treatment for stage II-III rectal cancer: a feasibility study.
Lupattelli M, Maranzano E, Bellavita R, Natalini G, Corgna E, Rossetti R, Trippa F, Mascioni F, Sidoni A, Anselmo P, Buzzi F, Brugia M, Latini P.
Lupattelli M, et al.
Tumori. 2005 Nov-Dec;91(6):498-504. doi: 10.1177/030089160509100610.
Tumori. 2005.
PMID: 16457149
Clinical Trial.